Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Oct;66(4):685–691. doi: 10.1038/bjc.1992.338

Sarcomas in north west England: III. Survival.

A L Hartley 1, V Blair 1, M Harris 1, J M Birch 1, S S Banerjee 1, A J Freemont 1, J McClure 1, L J McWilliam 1
PMCID: PMC1977430  PMID: 1419607

Abstract

Survival data on a population-based series of bone, soft tissue and visceral sarcomas diagnosed in the North West of England between 1982-84 and subjected to histopathological peer review are presented. Five-year crude survival for all cases was 34%. Survival in males and females did not differ significantly (P = 0.6, 5-year survival 32% vs 36%) but was markedly worse for patients diagnosed over the median age of 60 years, even when allowance was made for underlying mortality (P = 0.03, 34% vs 44%). Five-year survival rates for the major site groups were: bone 44%; soft tissues of head, neck and trunk 36%; soft tissues of extremities 35%; female genital tract 35%; retroperitoneum 15%; gastro-intestinal tract 13%. Analysis by the major histological types revealed the following survival rates: leiomyosarcoma--female genital tract 25%, gastro-intestinal tract 14%, non-visceral soft tissue 21%; malignant fibrous histiocytoma of soft tissue 29%; liposarcoma 52%; osteosarcoma of bone 46%; and chondrosarcoma of bone 50%.

Full text

PDF
685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnarsson B. A., Baldursson G., Benediktsdóttir K. R., Hrafnkelsson J. Tumours in Iceland. 14. Malignant tumours of soft tissues. Histological classification and epidemiological considerations. APMIS. 1991 May;99(5):443–448. doi: 10.1111/j.1699-0463.1991.tb05173.x. [DOI] [PubMed] [Google Scholar]
  2. Alvegård T. A., Berg N. O. Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol. 1989 Dec;7(12):1845–1851. doi: 10.1200/JCO.1989.7.12.1845. [DOI] [PubMed] [Google Scholar]
  3. Birch J. M., Marsden H. B., Jones P. H., Pearson D., Blair V. Improvements in survival from childhood cancer: results of a population based survey over 30 years. Br Med J (Clin Res Ed) 1988 May 14;296(6633):1372–1376. doi: 10.1136/bmj.296.6633.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bramwell V. H., Crowther D., Deakin D. P., Swindell R., Harris M. Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester. Br J Cancer. 1985 Mar;51(3):301–318. doi: 10.1038/bjc.1985.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bramwell V., Quirt I., Warr D., Verma S., Young V., Knowling M., Eisenhauer E. Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group. J Natl Cancer Inst. 1989 Oct 4;81(19):1496–1499. doi: 10.1093/jnci/81.19.1496. [DOI] [PubMed] [Google Scholar]
  6. Buckley J. D. Additive and multiplicative models for relative survival rates. Biometrics. 1984 Mar;40(1):51–62. [PubMed] [Google Scholar]
  7. Collin C., Godbold J., Hajdu S., Brennan M. Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol. 1987 Apr;5(4):601–612. doi: 10.1200/JCO.1987.5.4.601. [DOI] [PubMed] [Google Scholar]
  8. Craft A. W., Amineddine H. A., Scott J. E., Wagget J. The Northern region Children's malignant disease registry 1968-82: incidence and survival. Br J Cancer. 1987 Dec;56(6):853–858. doi: 10.1038/bjc.1987.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harris M., Hartley A. L., Blair V., Birch J. M., Banerjee S. S., Freemont A. J., McClure J., McWilliam L. J. Sarcomas in north west England: I. Histopathological peer review. Br J Cancer. 1991 Aug;64(2):315–320. doi: 10.1038/bjc.1991.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hartley A. L., Blair V., Harris M., Birch J. M., Banerjee S. S., Freemont A. J., McClure J., McWilliam L. J. Sarcomas in north west England: II. Incidence. Br J Cancer. 1991 Dec;64(6):1145–1150. doi: 10.1038/bjc.1991.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mandard A. M., Petiot J. F., Marnay J., Mandard J. C., Chasle J., de Ranieri E., Dupin P., Herlin P., de Ranieri J., Tanguy A. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer. 1989 Apr 1;63(7):1437–1451. doi: 10.1002/1097-0142(19890401)63:7<1437::aid-cncr2820630735>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  12. Markhede G., Angervall L., Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer. 1982 Apr 15;49(8):1721–1733. doi: 10.1002/1097-0142(19820415)49:8<1721::aid-cncr2820490832>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  13. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Presant C. A., Russell W. O., Alexander R. W., Fu Y. S. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol. 1986 Nov;4(11):1658–1661. doi: 10.1200/JCO.1986.4.11.1658. [DOI] [PubMed] [Google Scholar]
  15. Röser B., Attewell R., Berg N. O., Rydholm A. Prognostication in soft tissue sarcoma. A model with four risk factors. Cancer. 1988 Feb 15;61(4):817–823. doi: 10.1002/1097-0142(19880215)61:4<817::aid-cncr2820610429>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  16. Röser B., Willén H., Gustafson P., Alvegård T. A., Rydholm A. Malignant fibrous histiocytoma of soft tissue. A population-based epidemiologic and prognostic study of 137 patients. Cancer. 1991 Jan 15;67(2):499–505. doi: 10.1002/1097-0142(19910115)67:2<499::aid-cncr2820670230>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  17. Stiller C. A. Centralisation of treatment and survival rates for cancer. Arch Dis Child. 1988 Jan;63(1):23–30. doi: 10.1136/adc.63.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stotter A. T., A'Hern R. P., Fisher C., Mott A. F., Fallowfield M. E., Westbury G. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer. 1990 Mar 1;65(5):1119–1129. doi: 10.1002/1097-0142(19900301)65:5<1119::aid-cncr2820650515>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  19. Suit H. D., Mankin H. J., Wood W. C., Proppe K. H. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer. 1985 Jun 1;55(11):2659–2667. doi: 10.1002/1097-0142(19850601)55:11<2659::aid-cncr2820551122>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  20. Trojani M., Contesso G., Coindre J. M., Rouesse J., Bui N. B., de Mascarel A., Goussot J. F., David M., Bonichon F., Lagarde C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984 Jan 15;33(1):37–42. doi: 10.1002/ijc.2910330108. [DOI] [PubMed] [Google Scholar]
  21. Ueda T., Aozasa K., Tsujimoto M., Hamada H., Hayashi H., Ono K., Matsumoto K. Multivariate analysis for clinical prognostic factors in 163 patients with soft tissue sarcoma. Cancer. 1988 Oct 1;62(7):1444–1450. doi: 10.1002/1097-0142(19881001)62:7<1444::aid-cncr2820620733>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  22. el-Jabbour J. N., Akhtar S. S., Kerr G. R., McLaren K. M., Smyth J. F., Rodger A., Leonard R. C. Prognostic factors for survival in soft tissue sarcoma. Br J Cancer. 1990 Nov;62(5):857–861. doi: 10.1038/bjc.1990.394. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES